New obesity drug formulations tested in healthy volunteers
NCT ID NCT07220954
First seen Oct 31, 2025 · Last updated May 15, 2026 · Updated 22 times
Summary
This early-stage study tests different versions of an experimental drug called AZD6234 in 21 healthy adults with overweight or obesity. The goal is to see which formulation gets into the blood best and causes the fewest side effects. Participants receive a single injection and are monitored closely. This research helps determine the best way to give the drug in future trials.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Ruddington, NG11 6JS, United Kingdom
Conditions
Explore the condition pages connected to this study.